The company unveiled data in November 2024 from the EMPOWER-1 and EMPOWER-2 trials, neither of which met their primary ...

[9] as well as for the 30-item PANSS scale in total (TOT) and the original General Psychopathology subscale in Figure 6. Results suggest that the Positive and Negative subscales are more ...

After obtaining informed consent, baseline characteristics, PANSS scale, PSP, and social functioning scale were assessed and recorded. Treatment of these subjects was decided by clinicians' opinion.